甲状腺乳头状癌伴桥本甲状腺炎患者中央淋巴结转移的危险因素及术前预测价值

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (975 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨甲状腺乳头状癌(PTC)伴桥本甲状腺炎(HT)患者中央淋巴结转移的危险因素及术前预测价值。方法回顾性分析2020-01至2022-12武警特色医学中心收治的257例PTC伴HT患者的基本信息、术前超声特征和甲状腺功能。根据有或无中央淋巴结转移分为两组,使用多因素logistic回归分析探讨影响中央淋巴结转移的危险因素。结果 257例中有118例(45.91%)存在中央淋巴结转移。与无中央淋巴结转移患者比较,中央淋巴结转移患者的平均血清TGAb水平高,血清TPOAb水平低(P=0.00)。多因素logistic回归分析显示,肿瘤位置(中部OR=2.162,95%CI:1.892～2.470,P=0.000;下部OR= 6.763,95%CI:3.647～12.53,P=0.000)、中央淋巴结边缘不规则(OR=3.535,95%CI:1.303～9.586,P=0.013)、中央淋巴结微钙化(OR=9.916,95%CI:5.264～18.67,P=0.000)、血清TGAb水平升高(OR=7.124,95%CI:1.560～1.905,P=0.000)是PTC伴HT患者中央淋巴结转移发生的独立危险因素。结论术前超声特征结合血清TGAb水平可以预测PTC伴HT患者的中央淋巴结转移情况。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	孙甲甲
	周广磊
	任含笑

关键词 ：甲状腺癌, 中央淋巴结转移, 无创, 危险因素

Abstract：Objective To investigate the risk factors and preoperative prediction value of central lymph node metastasis in patients with papillary thyroid carcinoma (PTC) and Hashimoto's thyroiditis (HT).Methods A retrospective analysis was conducted on the basic information, preoperative ultrasound features, and thyroid function of 257 PTC patients with HT admitted to Characters Medical Center of Chinese People's Armed Police Force from January 2020 to December 2022. The patients were divided into two groups based on the presence or absence of central lymph node metastasis. Multivariate logistic regression analysis was used to explore the risk factors affecting central lymph node metastasis.Results Among the 257 PTC patients, 118 (45.91%) cases had central lymph node metastasis. Compared with the patients without central lymph node metastasis, patients with central lymph node metastasis had higher levels of serum TGAb (P=0.000) and lower levels of serum TPOAb (P=0.00). Multivariate logistic regression analysis showed that the tumor location (central OR=2.162,95%CI: 1.892-2.470, P=0.000, lower OR=6.763,95%CI: 3.647-12.53, P=0.000) and the central lymph node margin were irregular (OR=3.535,95% CI: 1.303-9.586, P=0.013); Microcalcification of central lymph nodes (OR=9.916,95%CI:5.264-18.67,P=0.000) and elevated serum TGAb levels (OR=7.124,95%CI:1.560-1.905, P=0.000) were independent risk factors for central lymph node metastasis in PTC with HT patients.Conclusions Preoperative ultrasound features combined with serum TGAb levels can predict central lymph node metastasis in patients with PTC and HT.

Key words： thyroid cancer central lymph node metastasis non-invasive risk factors

收稿日期: 2023-03-06

ZTFLH:

R736.1

基金资助:山东省自然科学基金青年项目(ZR2020QH278)

作者简介: 孙甲甲,硕士研究生,主治医师。

引用本文:

孙甲甲, 周广磊, 任含笑. 甲状腺乳头状癌伴桥本甲状腺炎患者中央淋巴结转移的危险因素及术前预测价值[J]. 武警医学, 2023, 34(9): 737-741. SUN Jiajia, ZHOU Guanglei, REN Hanxiao. Risk factors analysis and preoperative prediction value of central lymph node metastasis in patients with papillary thyroid cancer and Hashimoto's thyroiditis. Med. J. Chin. Peop. Armed Poli. Forc., 2023, 34(9): 737-741.

链接本文:

http://journal08.magtechjournal.com/Jwk_wjyx/CN/ 或 http://journal08.magtechjournal.com/Jwk_wjyx/CN/Y2023/V34/I9/737

[1]	Pasqual E,Sosa J A,ChenY,et al.Trends in the management of localized papillary thyroid carcinoma in the United States (2000-2018) [J].Thyroid, 2022,32(4):397-410.
[2]	中华人民共和国国家卫生健康委员会医政医管局.甲状腺癌诊疗指南(2022年版)[J].中国实用外科杂志,2022,42(12):1343-1357,1363.
[3]	Lebbink C A,Links T P,Czarniecka A,et al. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma[J].Eur Thyroid J,2022,11(6):e220146.
[4]	姜可伟,王晨一.甲状腺癌临床研究现状和热点[J].中华普通外科杂志,2021,36(6):401-404.
[5]	张亚萍,王朝晖.甲状腺球蛋白抗体和甲状腺过氧化物酶抗体在合并桥本氏甲状腺炎的甲状腺乳头状癌患者诊治中的意义[J].中华内分泌外科杂志,2022,16(2):248-250.
[6]	Song E,Jeon M J, Park S, et al. Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma[J].Clin Endocrinol (Oxf),2018,88(1):123-128.
[7]	Sugitani I,Ito Y,Miyauchi A,et al. Active surveillance versus immediate surgery: questionnaire survey on the current treatment strategy for adult patients with low-risk papillary thyroid microcarcinoma in Japan[J].Thyroid, 2019,29(11):1563-1571.
[8]	张晓梅,康燕飞,桑田,等.超声检查指标联合预测甲状腺乳头状癌颈部中央淋巴结转移的价值研究[J].中国全科医学,2022,25(3): 305-311.
[9]	张佩,卢苇,宋琳琳,等.Ⅵc亚分区在预测cN0单侧甲状腺乳头状癌对侧中央淋巴结转移中的价值探讨[J].中国普外基础与临床杂志,2022,29(10):1339-1343.
[10]	Wen X,Wang B,Jin Q,et al. Thyroid antibody status is associated with central lymph node metastases in papillary thyroid carcinoma patients with Hashimoto's thyroiditis [J].Ann Surg Oncol,2019,26(6):1751-1758.
[11]	张桂萍,詹维伟.儿童及青少年甲状腺癌超声诊断[J].中国实用外科杂志,2022,42(6):643-648.
[12]	王卉,赵珊珊,姚劲草,等.超声联合甲状腺球蛋白检测对甲状腺癌术前N分期的价值分析[J].中华超声影像学杂志,2022,31(2):122-128.
[13]	Xue S,Han Z,Lu Q,et al. Clinical and ultrasonic risk factors for lateral lymph node metastasis in papillary thyroid microcarcinoma: a systematic review and meta-analysis [J].Front Oncol,2020,10:436.
[14]	Back K,Kim J S,Kim J H,et al. Superior located papillary thyroid microcarcinoma is a risk factor for lateral lymph node metastasis[J].Ann Surg Oncol,2019,26(12):3992-4001.
[15]	Sun W,Lan X,Zhang H,et al.Riskfactors for central lymph node metastasis in cn0 papillary thyroid carcinoma: a systematic review and meta-analysis [J].PLoS One,2015,10(10):e0139021.
[16]	Kim H,Park S Y,Choe J H,et al. Preoperative serum thyroglobulin and its correlation with the burden and extent of differentiated thyroid cancer[J].Cancers (Basel),2020,12(3):625.
[17]	姚玉唐,张穆斯,江骁,等.细针穿刺洗脱液甲状腺球蛋白测定在甲状腺乳头状癌淋巴结转移诊断中的价值[J].肿瘤预防与治疗,2021,34(4):328-334.
[18]	张雪鹤.甲状腺超声联合血清Tg、TgAb对甲状腺癌术后复发诊断中的作用[J].河北医科大学学报,2022,43(4):455-459,465.